Merck & Co. Overview
- Founded
- 1891

- Status
- Public
- Employees
- 71,000

- Stock Symbol
- MRK

- Investments
- 67
- Share Price
- $82.46
- (As of Wednesday Closing)
Merck & Co. General Information
Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States.
Contact Information
- 2000 Galloping Hill Road
- Kenilworth, NJ 07033
- United States
Merck & Co. Stock Performance
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$82.46 | $83.19 | $65.25 - $90.46 | $210B | 2.53B | 8.95M | $4.55 |
Merck & Co. Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 229,673,547 | 249,714,258 | 212,235,768 | 169,355,061 |
Revenue | 47,347,000 | 46,840,000 | 42,294,000 | 40,122,000 |
EBITDA | 17,978,000 | 15,735,000 | 13,649,000 | 11,566,000 |
Net Income | 11,517,000 | 9,843,000 | 6,220,000 | 2,394,000 |
Total Assets | 89,800,000 | 84,397,000 | 82,637,000 | 87,872,000 |
Total Debt | 28,741,000 | 26,346,000 | 25,114,000 | 24,410,000 |
Merck & Co. Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Merck & Co.‘s full profile, request access.
Request a free trialMerck & Co. Comparisons
Industry
00000
000 0000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialMerck & Co. Competitors (60)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Amgen | Formerly PE-Backed | Thousand Oaks, CA | 00000 | 00.000 | 000000000000 | 00.000 |
000 00000 | Corporation | Indianapolis, IN | 00000 | 000000 - 000 | ||
000000 00000000 | Formerly VC-backed | Foster City, CA | 00000 | 00.000 | 000000&0 | |
0000000-00000 0000 | Corporation | New York, NY | 00000 | 00000 | 000000000 | 00000 |
00000000 | Corporation | Basel, Switzerland | 000000 | 000000000000 |
Merck & Co. Executive Team (72)
Merck & Co. Board Members (22)
Name | Representing | Role | Since |
---|---|---|---|
000000000 0000000 00 | Self | Board Member | 000 0000 |
0000 000000 | Merck & Co. | Board Member | 000 0000 |
00000 000000 | Self | Board Member | 000 0000 |
0000000 0000000 00 | Merck & Co. | Chief Executive Officer and Chairman of the Board | 000 0000 |
000000 0000 | Self | Board Member | 000 0000 |
Merck & Co. Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialMerck & Co. Investments & Acquisitions (67)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00 000000000000000 | 23-Dec-2020 | 000000000 | Drug Discovery | 00000 0000000000 00.0 | |
00000000 | 18-Dec-2020 | 000000000000000000 | 00.000 | Drug Discovery | 00000 0000000000 00.0 |
0000000000 | 23-Nov-2020 | 000000000000000000 | 00000 | Drug Discovery | 00000 0000000000 00.0 |
00000 000000 (0000 | 27-Jul-2020 | 000000000 00000 00 | 0000 | Buildings and Property | |
Yumanity Therapeutics | 24-Jun-2020 | Later Stage VC | 000.00 | Drug Discovery | 00000 00000000 00.0 |
Merck & Co. Subsidiaries (20)
Company Name | Industry | Location | Founded |
---|---|---|---|
VelosBio | Drug Discovery | San Diego, CA | 2017 |
00000 000000000000 | Biotechnology | Lexington, MA | 0000 |
0000000 0000000000 | Pharmaceuticals | Dallas, TX | 0000 |
00000 000000 00000 | Corporate Venture Capital | Kenilworth, NJ | 0000 |
0000000000 | Biotechnology | Australia | 0000 |
Merck & Co. Exits (23)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
00000000 000000000 | 24-Jun-2020 | 00000 00000 00 | 000.00 | Completed |
|
0000000 | 25-Jul-2018 | 00000 00000 00 | 00000 | Completed |
|
00000000 0000 0000 | 01-Aug-2016 | 00000 00000 00 | 0000 | Completed |
|
0000000 | 07-Jan-2016 | 00000 00000 00 | 000.00 | Completed |
|
Quartet Medicine | 06-Jan-2016 | Corporate | 0000 | Completed |